Status:
COMPLETED
Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome
Lead Sponsor:
Assiut University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-35 years
Phase:
PHASE2
Brief Summary
In 1935 the polycystic ovary syndrome was a clinical diagnosis made on the morphological appearance of the ovaries in association with amenorrhoea, hirsutism and frequently obesity. At that time wedge...
Eligibility Criteria
Inclusion
- Infertility more than 2 years.
- Age between 20-35 years.
- clomiphene resistant patients: Patients received clomiphene 150 mg from day 3 to 7 of the menstrual cycle for 6 months and non-ovulatory (with failure of conception). They were followed up in the outpatient clinic.
- No contraindications for laparoscopy.
- Normal Hysterosalpingography
Exclusion
- Contraindications for laparoscopy e.g cardiac diseases, bad scared abdomen ect….
- Women's age less than 20 years or more than 35 years.
- Previous Laparoscopic surgery.
- Previous ovarian surgery.
- Women with Antimullerian hormone level less than 4 ng/ml.
- Tubal factor infertility as diagnosed by Hysterosalpingography .
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03237312
Start Date
January 1 2015
End Date
November 30 2016
Last Update
August 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women Health Hospital - Assiut university
Asyut, Egypt, 71111